| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | (Small) Mothers Against Decapentaplegic ELISA Kit; Deleted in Pancreatic Carcinoma 4 ELISA Kit; Deleted in Pancreatic Carcinoma ELISA Kit; Deleted in pancreatic carcinoma locus 4 ELISA Kit; Deletion target in pancreatic carcinoma 4 ELISA Kit; DPC 4 ELISA Kit; DPC4 ELISA Kit; hSMAD4 ELISA Kit; JIP ELISA Kit; MAD homolog 4 ELISA Kit; MAD mothers against decapentaplegic Drosophila homolog 4 ELISA Kit; MAD mothers against decapentaplegic homolog 4 ELISA Kit; MADH 4 ELISA Kit; MADH4 ELISA Kit; Med ELISA Kit; Medea ELISA Kit; Mothers against decapentaplegic homolog 4 ELISA Kit; Mothers against decapentaplegic; Drosophila; homolog of; 4 ELISA Kit; Mothers against DPP homolog 4 ELISA Kit; MYHRS ELISA Kit; OTTHUMP00000163548 ELISA Kit; SMA- and MAD-related protein 4 ELISA Kit; SMAD 4 ELISA Kit; SMAD family member 4 ELISA Kit; SMAD mothers against DPP homolog 4 ELISA Kit; SMAD4 ELISA Kit; SMAD4_HUMAN ELISA Kit |
| Assay Time | |
| Assay Type | |
| Detection Range | |
| Detection Wavelength | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | serum, plasma, tissue homogenates, cell lysates |
| Sensitivity | |
| Species | |
| Target | |
| UniProt # |
Background
Mothers against decapentaplegic homolog 4 (SMAD4) is a biological molecule commonly studied in epigenetics and nuclear signaling research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.
UniProt: Q13485
Biological context
Researchers often monitor Mothers against decapentaplegic homolog 4 in serum, plasma, tissue homogenates, and cell lysates to better understand themes such as mechanistic biology studies, biomarker-focused profiling, and disease-model research. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.
Interpreting changes in measured levels
Depending on sample matrix and study design, increases or decreases in Mothers against decapentaplegic homolog 4 may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, complementary pathway markers and controls appropriate to the biological model) and by keeping pre-analytical variables consistent across groups.
Nomenclature
In publications and databases, Mothers against decapentaplegic homolog 4 may also appear under names such as (Small) Mothers Against Decapentaplegic and Deleted in Pancreatic Carcinoma 4. When comparing studies, confirm that the reported analyte refers to the same molecule and species context.
Why ELISA data are widely used
ELISA is a common approach for quantitative measurement of proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that Mothers against decapentaplegic homolog 4 participates in.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
SMAD4 Expression in Monocytes as a Potential Biomarker for Atherosclerosis Risk in Patients with Obstructive Sleep Apnea
E Díaz-García,International journal of molecular sciences,2023